NasdaqGM:IRMDMedical Equipment
Reaffirmed 2026 Guidance and Dividend Policy Could Be A Game Changer For IRADIMED (IRMD)
IRADIMED CORPORATION recently reported past second-quarter 2026 results, showing sales of US$20.47 million and net income of US$5.22 million, alongside affirming a regular US$0.20 per-share dividend and issuing updated revenue and earnings guidance for the third quarter and full year.
While quarterly profit softened slightly year over year, the combination of steady first-half revenue growth, continued dividend payments, and detailed earnings guidance offers investors a clearer picture of...